Viewing Study NCT00378105


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2025-12-26 @ 2:06 AM
Study NCT ID: NCT00378105
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-28
First Post: 2006-09-18
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
Sponsor: Dana-Farber Cancer Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-09
Start Date Type: ACTUAL
Primary Completion Date: 2009-07
Primary Completion Date Type: ACTUAL
Completion Date: 2025-12
Completion Date Type: ESTIMATED
First Submit Date: 2006-09-18
First Submit QC Date: None
Study First Post Date: 2006-09-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-10-15
Results First Submit QC Date: None
Results First Post Date: 2014-08-19
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-14
Last Update Post Date: 2025-02-28
Last Update Post Date Type: ACTUAL